Human Umbilical Cord Mesenchymal Stem Cells Modulate Cytokine Secretion of CD4 + T Cell in Systemic Lupus Erythematosus by Inhibiting HSP90AA1 in the Glucose‐Activated PI3K‐AKT Pathway
Immunity, Inflammation and Disease · 2025-08 · 13 (8)
DOI: 10.1002/iid3.70239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 13.08.2025. Verfasst von Lu Jin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Mesenchymal Stem Cells, CD4-Positive T-Lymphocytes, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by Medical Science Research Project of Hebei (20220098, 20240127); Natural Science Foundation of Hebei Province (H2019206387 and H2023206….
Abstract (Originalsprache)
Objective
Treatment with human umbilical cord mesenchymal stem cells (hUC‐MSCs) attenuated the clinical manifestations of systemic lupus erythematosus (SLE). We investigated the metabolic mechanism whereby hUC‐MSCs modify CD4 + T cell cytokine secretion in lupus.
Methods
The study enrolled 30 untreated lupus patients and 20 sex, age, and body mass index matched healthy controls (HCs). CD4 + T cells were isolated by magnetic sorting, and stimulated with anti‐CD3/CD28. The hUC‐MSCs treatment (MSCT) groups were coculturing hUC‐MSCs to CD4 + T cells from moderate and severe SLE (SLE‐MS) groups for 72 h at ratios of 1:25 (T1), 1:10 (T2), and 1:5 (T3). Cytokine concentration and proliferation of the CD4 + T cells were measured by Luminex liquid chip assay and cell counting kit‐8, respectively. Glucose metabolic capacity was measured by Seahorse real‐time metabolic analysis. The role of hUC‐MSCs on cytokine secretion was analyzed by transcriptome sequencing. Glucose enzymes levels and HSP90AA1/PI3K/AKT pathway activity were analyzed by real‐time quantitative PCR and western blot. The CD4 + T cell subsets were detected by flow cytometry.
Results
Compared with HCs, the enhanced glycolysis and mitochondrial oxygen consumption of SLE‐CD4 + T cells were positively associated with disease activity. Treatment with hUC‐MSCs proportionally decreased glucose metabolism and proliferation of SLE‐CD4 + T cells. The hUC‐MSCs treatment significantly diminished supernatant concentrations of interferon‐γ, tumor necrosis factor‐α, interleukin (IL)‐4, and IL‐17 in SLE‐MS group, as well as inhibited HSP90AA1 in the glucose‐activated PI3K‐AKT pathway. In animal experiment, the systemic administration of hUC‐MSCs and inhibition of HSP90AA1 resulted in a reduction of glucose metabolites, enzymes, pro‐inflammatory factor levels, and HSP90AA1 / PI3K/AKT signaling pathway activity.
Conclusions
The hUC‐MSCs treatment inhibited overactive glucose metabolism of SLE‐CD4 + T cells. HSP90AA1 in the PI3K‐AKT pathway induced by the glucose metabolism may be involved in the anti‐inflammatory function of hUC‐MSCs treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Hebei International Joint Research Center on Rheumatic Diseases, Shijiazhuang, Hebei, China.
- Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, Hebei, China.
- Hebei Key Laboratory of Laboratory Medicine, Shijiazhuang, Hebei, China.
- Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, Hebei, China.
ORCID-Profile: Lu Jin, Aijing Liu
Förderung
- This study was funded by Medical Science Research Project of Hebei (20220098, 20240127); Natural Science Foundation of Hebei Province (H2019206387 and H2023206…
Zitieren
APA
Jin, L., Ding, M., Cui, S., Yang, L., He, J., Wang, X., Chang, F., Yu, J., Yang, Y., Jin, H., Shi, M., Ma, J., & Liu, A. (2025). Human Umbilical Cord Mesenchymal Stem Cells Modulate Cytokine Secretion of CD4 + T Cell in Systemic Lupus Erythematosus by Inhibiting HSP90AA1 in the Glucose‐Activated PI3K‐AKT Pathway. Immunity, Inflammation and Disease, 13(8). https://doi.org/10.1002/iid3.70239
Vancouver
Jin L, Ding M, Cui S, Yang L, He J, Wang X, et al. Human Umbilical Cord Mesenchymal Stem Cells Modulate Cytokine Secretion of CD4 + T Cell in Systemic Lupus Erythematosus by Inhibiting HSP90AA1 in the Glucose‐Activated PI3K‐AKT Pathway. Immunity, Inflammation and Disease. 2025;13(8). doi:10.1002/iid3.70239
BibTeX
@article{Jin2025,
author = {Jin, Lu and Ding, Meng and Cui, Shaoxin and Yang, Lin and He, Jingjing and Wang, Xiaoping and Chang, Fei and Yu, Jingjing and Yang, Yiming and Jin, Hongtao and Shi, Min and Ma, Jun and Liu, Aijing},
title = {Human Umbilical Cord Mesenchymal Stem Cells Modulate Cytokine Secretion of CD4 + T Cell in Systemic Lupus Erythematosus by Inhibiting HSP90AA1 in the Glucose‐Activated PI3K‐AKT Pathway},
journal = {Immunity, Inflammation and Disease},
year = {2025},
volume = {13},
number = {8},
doi = {10.1002/iid3.70239}
}
EUVIMED